Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.

Key Points Traditional companies in banking, agriculture, and materials are quietly deploying artificial intelligence (AI) to transform operations and create competitive advantages that investors are overlooking.

The artificial intelligence moment is upon humanity. Unfortunately, there is no going back except the mind-boggling advancements. The AI enthusiasts follow the Silicon Valley mantra

AI is dumbing us down. But paradoxically, when used judiciously in combination with human thought, the very same tool could be a doorway to increased wisdom.

The artificial intelligence (AI) market expanded rapidly in recent years as new generative AI platforms like OpenAI's ChatGPT changed how companies process data, automate tasks, and serve their customers. The biggest winner in that AI boom was Nvidia (NASDAQ: NVDA), the world's leading producer of the GPUs that handled those complex tasks.

OpenAI convinced a federal judge in California on Monday that a Silicon Valley tech entrepreneur violated its trademark rights by using the name "Open AI" in commerce.

As artificial intelligence transforms how we order food and how restaurants connect with customers, let's take a look at a few ways this is happening today.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool Foundation.

Artificial Intelligence is reshaping the job market faster than ever. This video explores how AI will impact careers and what the future workforce might look like.

Subtle asymmetries in a horse's movement can be easy to miss, especially under time pressure or with unfamiliar horses; an app is now helping regulatory vets keep racehorses safer

Nvidia's GPUs are powering the AI arms race. Nvidia is poised for massive upside if the projection proves to be true. Nvidia (NASDAQ: NVDA) has is now the world's largest company, creating a sizable gap between itself and second-place Microsoft (NASDAQ: MSFT).

Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often than commonly thought, clinical trials are also uninformative.1 Artificial intelligence (AI) could offer an unprecedented opportunity to streamline the clinical trial lifecycle—from design to reporting—and improve the informativeness of the generated results.